U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2328123281Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterionâ„¢ Capsule Compared to an Immediate Release Formulation in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: KUC 7483 CL, immediate release tablet|Drug: KUC 7483 CL, particulate formulation|Drug: KUC 7483 CL, solution formulation|Device: Enterionâ„¢ capsulehttps://ClinicalTrials.gov/show/NCT02259920
2328223282Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: KUC 7483 CL|Drug: Placebo|Other: High fat mealhttps://ClinicalTrials.gov/show/NCT02259907
2328323283Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIRT 2584 XX|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02259894
2328423284Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Low dose of BIBT 986 CL, per i.v. infusion|Drug: Medium dose of BIBT 986 CL, per i.v. infusion|Drug: High dose of BIBT 986 CL, per i.v. infusion|Drug: Placebo|Drug: Lipopolysaccharide (LPS), single i.v. bolushttps://ClinicalTrials.gov/show/NCT02259881
2328523285Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer SubjectsCompletedNo Results AvailableHealthyDrug: BILR 355 BS /1B, current low dose formulation|Drug: BILR 355 BS /1B, current high dose formulation|Drug: BILR 355 BS - Jet Milled (JM) + Sodium Dodecyl Sulfate (SDS) formulation|Drug: BILR 355 BS - Hammer Milled (HM) + Sodium Dodecyl Sulfate (SDS) formulation|Drug: BILR 355 BS - Suspension low dose|Drug: BILR 355 BS - Suspension high dose|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02259868
2328623286Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ICompletedNo Results AvailableHepatic InsufficiencyDrug: Tipranavir|Drug: Ritonavir|Drug: Pegylated interferon|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT02259855
2328723287Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 34021 FU2 solution|Drug: BI 34021 FU2 tablet|Drug: Placebo|Other: High fat, high calorie breakfasthttps://ClinicalTrials.gov/show/NCT02259842
2328823288Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan/Amlodipine|Drug: Telmisartan|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT02259829
2328923289Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT02259816
2329023290Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan/amlodipine fixed-dose combination (FDC) tablet|Drug: Telmisartan|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT02259803
2329123291Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan/amlodipine fixed-dose combination tablet|Drug: Telmisartan|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT02259790
2329223292Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan/Amlodipine|Other: high fat, high caloric mealhttps://ClinicalTrials.gov/show/NCT02259777
2329323293Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: KUC 7483 CL - single rising dose|Drug: Placebo|Other: standardized high fat mealhttps://ClinicalTrials.gov/show/NCT02259764
2329423294Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor OveractivityCompletedNo Results AvailableSpinal Cord InjuriesDrug: KUC 7483 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02259751
2329523295Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary KallidinogenaseCompletedNo Results AvailableCerebral InfarctionDrug: Human Urinary Kallidinogenase|Drug: Shuxuening injectionhttps://ClinicalTrials.gov/show/NCT02259738
2329623296Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsNot yet recruitingNo Results AvailableGastrinoma|Glucagonoma|Insulinoma|Metastatic Gastrointestinal Carcinoid Tumor|Pancreatic Polypeptide Tumor|Pulmonary Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Islet Cell Carcinoma|SomatostatinomaDrug: regorafenib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT02259725
2329723297Effectiveness of Hipopressive Exercises Versus Classical Perineal PhysiotherapyRecruitingNo Results AvailablePelvic Floor Disorders|Urinary Incontinence|Fecal Incontinence|Pelvic PainOther: Hipopressive exercises|Behavioral: Therapeutic education.|Other: Pelviperineal physiotherapy|Other: Physical Therapy assessmenthttps://ClinicalTrials.gov/show/NCT02259712
2329823298Ovarian Cancer Patient-Centered Decision AidRecruitingNo Results AvailableStage III Ovarian CancerOther: Decision Aidhttps://ClinicalTrials.gov/show/NCT02259699
2329923299Cardiovascular Effects of Apelin In Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Apelin 1mg subcutaneous|Drug: Apelin 1mg intravenous|Drug: Apelin 5mg subcutaneous|Drug: Apelin 5mg intravenous|Drug: Apelin 10 mg subcutaneoushttps://ClinicalTrials.gov/show/NCT02259686
2330023300Effects of Fun Physical Activity on the Interest to Daily Physical Activity and Sarcopenia of Elderly PeopleRecruitingNo Results AvailableActivityOther: Fun exercise|Other: fun exercisehttps://ClinicalTrials.gov/show/NCT02259673
2330123301Airway Muscle Training for Obstructive Sleep ApneaRecruitingNo Results AvailableObstructive Sleep ApneaDevice: Respiratory muscle strength traininghttps://ClinicalTrials.gov/show/NCT02259660
2330223302Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaDrug: Sorafenib 400mg twice daily + intravenous infusion ofVit K1|Drug: Sorafenib 400 mg twice daily + Intravenousinfusion of placebohttps://ClinicalTrials.gov/show/NCT02259647
2330323303Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated PatientsTerminatedNo Results AvailableHIV/AIDS|Diabetes Mellitus|Hypertension|Substance UseBehavioral: Patient Navigationhttps://ClinicalTrials.gov/show/NCT02259634
2330423304Neoadjuvant Anti-PD-1, Nivolumab in Resectable NSCLCRecruitingNo Results AvailableNon-Small Cell Lung CancerDrug: Nivolumabhttps://ClinicalTrials.gov/show/NCT02259621
2330523305γ-irradiated BCG to Train Innate ImmunityCompletedNo Results AvailableInnate Immune ResponseBiological: BCG vaccine SSIhttps://ClinicalTrials.gov/show/NCT02259608
2330623306Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NACCompletedNo Results AvailableHearing Loss|Sensorineural Hearing Loss|Noise-Induced Hearing LossDrug: HPN-07|Drug: NAC|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02259595
2330723307A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung CancerRecruitingNo Results AvailableNonsquamous Nonsmall Cell Neoplasm of LungDrug: Pemetrexed|Drug: Carboplatin|Drug: demcizumabhttps://ClinicalTrials.gov/show/NCT02259582
2330823308Comparison of Peak Airway Pressure and Gastric Insufflation in Pressure-Controlled Ventilation or Volume-Controlled Ventilation With I-Gel in Pediatric PatientCompletedNo Results AvailablePediatric Urologic SurgeriesOther: Pressure-controlled ventilation|Other: Volume-controlled ventilationhttps://ClinicalTrials.gov/show/NCT02259569
2330923309CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive LymphomasRecruitingNo Results AvailableHodgkin's Lymphoma|Non-Hodgkin's LymphomaBiological: CART30https://ClinicalTrials.gov/show/NCT02259556
2331023310Root Biomodification With Citric Acid and Tetracycline Improves the Outcomes of Root CoverageCompletedNo Results AvailableGingival RecessionOther: Root conditioning with citric acid+tetracycline solutionhttps://ClinicalTrials.gov/show/NCT02259543

* Görseller ve İçerik tekif hakkına sahip olabilir